What is the latest NATHBIOGEN stock price?
The latest stored price for NATHBIOGEN is Rs 147.34 as of 2026-09-18.
gimli
NATHBIOGEN stock AI analysis
NATHBIOGEN Stock AI Analysis: Price, PE, 50DMA, Shareholding and Peers
NATH BIO-GENES (I) LTD is a small-cap stock in Fast Moving Consumer Goods. This Gimli page shows the latest available NATHBIOGEN price, returns, 50DMA/200DMA trend, PE, ROE, ROCE, financials, shareholding pattern, and industry peers for Indian stock screening research.
Price
₹147.34
1W return
-3.39%
1M return
-5.05%
3M return
-14.34%
6M return
+2.87%
1Y return
-11.19%
Market cap
₹280.00 cr
PE
7.65
PB
0.41
ROE
+5.53%
ROCE
+7.62%
RSI
36.19
Turnover
₹0.80 cr
Why it can matter in screens
- Momentum: NATHBIOGEN is below 50DMA, below 200DMA; RSI is 36.19.
- Returns: 1D -0.54%, 1W -3.39%, 1M -5.05%, 3M -14.34%, 1Y -11.19%.
- Trend levels: 52W high ₹180.69, 52W low ₹141.30, off high -18.46%.
- Liquidity: latest turnover is ₹0.80 cr; volume vs 20D is +4.16%.
- Valuation/profitability: PE 7.65, PB 0.41, ROE +5.53%, ROCE +7.62%.
- Growth: 3Y sales CAGR +13.88%, 3Y profit CAGR +5.94%.
Quick Answers
Is NATHBIOGEN above its 50DMA and 200DMA?
NATHBIOGEN is below 50DMA, below 200DMA. The latest 50DMA is 156.56 and the latest 200DMA is 156.64.
What are NATHBIOGEN PE, ROE and ROCE?
NATHBIOGEN has PE 7.65, ROE +5.53%, and ROCE +7.62% in Gimli's latest available snapshot.
How has NATHBIOGEN performed recently?
NATHBIOGEN has returned -5.05% over 1 month, -14.34% over 3 months, and -11.19% over 12 months in the latest stored data.
Is this stock page investment advice?
No. This page is a data snapshot for screening and research. It is not buy, sell, legal, tax, or investment advice.
Financials and Ownership
Quarterly income statement
| Period | Revenue | EBITDA | PAT | EPS |
|---|---|---|---|---|
| 2026-06-30 | 328.40 cr | 38.25 cr | 32.26 cr | 16.98 |
| 2026-03-31 | 51.59 cr | 8.11 cr | -0.01 cr | -0.79 |
| 2025-12-31 | 65.96 cr | 8.00 cr | 1.60 cr | 0.84 |
| 2025-09-30 | 43.85 cr | 10.10 cr | 2.75 cr | 1.40 |
| 2025-06-30 | 283.70 cr | 40.05 cr | 37.28 cr | 19.58 |
| 2025-03-31 | 51.97 cr | 4.28 cr | 1.48 cr | 0.42 |
Annual income statement
| Year | Revenue | EBITDA | PAT | EPS |
|---|---|---|---|---|
| 2026-03-31 | 445.10 cr | 66.26 cr | 41.63 cr | 20.98 |
| 2025-03-31 | 364.91 cr | 54.34 cr | 38.60 cr | 20.14 |
| 2024-03-31 | 332.62 cr | 56.72 cr | 39.62 cr | 20.85 |
| 2023-03-31 | 301.36 cr | 51.76 cr | 35.01 cr | 18.43 |
| 2022-03-31 | 280.22 cr | -49.69 cr | -67.34 cr | -35.52 |
Balance sheet
| Period | Assets | Cash | Debt | Equity |
|---|---|---|---|---|
| 2026-03-31 | 1,097.42 cr | 76.00 cr | 138.50 cr | 680.46 cr |
| 2025-03-31 | 1,026.21 cr | 88.53 cr | 122.50 cr | 644.39 cr |
| 2024-03-31 | 880.23 cr | 77.13 cr | 110.35 cr | 609.92 cr |
| 2023-03-31 | 792.80 cr | 37.99 cr | 105.21 cr | 573.17 cr |
Cash flow
| Period | OCF | FCF | Cash change |
|---|---|---|---|
| 2026-03-31 | -12.57 cr | -15.58 cr | n/a |
| 2025-03-31 | 17.58 cr | 9.66 cr | n/a |
| 2024-03-31 | 74.59 cr | 47.82 cr | n/a |
| 2023-03-31 | 38.37 cr | 35.82 cr | n/a |
| 2022-03-31 | n/a | n/a | n/a |
Shareholding Trend
| Period | Promoter | FII/FPI | DII | MF | Retail | Pledge |
|---|---|---|---|---|---|---|
| 2026-06-30 | +45.60% | +0.27% | +0.01% | +0.01% | +54.13% | +13.78% |
| 2026-03-31 | +45.60% | +0.23% | +0.01% | +0.01% | +54.17% | +13.78% |
| 2025-12-31 | +45.60% | +0.31% | +0.01% | +0.01% | +54.08% | +13.78% |
| 2025-09-30 | +45.60% | +0.32% | +0.76% | +0.76% | +53.32% | +13.78% |
| 2025-06-30 | +45.60% | +0.42% | +2.25% | +2.25% | +51.74% | +13.78% |
| 2025-03-31 | +45.60% | +0.21% | +3.94% | +3.89% | +50.25% | +16.38% |
| 2024-12-31 | +45.60% | +0.19% | +4.37% | +4.37% | +49.84% | +16.38% |
| 2024-09-30 | +45.60% | +0.19% | +4.37% | +4.37% | +49.85% | +16.38% |
| 2024-06-30 | +45.60% | +0.22% | +4.38% | +4.37% | +49.81% | +16.38% |
| 2024-03-31 | +45.60% | +0.27% | +4.37% | +4.37% | +49.76% | +16.38% |
| 2023-12-31 | +45.60% | +0.32% | +4.37% | +4.37% | +49.72% | +16.38% |
| 2023-09-30 | +45.60% | +0.22% | +4.37% | +4.37% | +49.81% | +16.38% |
| 2023-06-30 | +45.60% | +0.08% | +4.62% | +4.62% | +49.71% | +16.38% |
| 2023-03-31 | +45.60% | +0.13% | +4.62% | +4.62% | +49.65% | +16.38% |
| 2022-12-31 | +45.60% | +0.15% | +4.62% | +4.62% | +49.63% | +16.38% |
| 2022-09-30 | +45.60% | +0.02% | +4.62% | +4.62% | +49.77% | +16.38% |
| 2022-06-30 | +41.07% | +0.00% | +4.73% | n/a | n/a | +9.34% |
| 2022-03-31 | +41.05% | +0.00% | +4.92% | n/a | n/a | +8.38% |
| 2021-12-31 | +41.03% | +0.00% | +7.21% | n/a | n/a | +16.47% |
| 2021-09-30 | +41.03% | +0.00% | +9.39% | n/a | n/a | +15.18% |
Industry Peers
| Symbol | Name | Mcap | PE | ROE | 1Y |
|---|---|---|---|---|---|
| HINDUNILVR | HINDUSTAN UNILEVER LTD. | 453,941.04 cr | 30.331487 | +30.35% | -25.31% |
| ITC | ITC LTD | 328,647.95 cr | 16.514732 | +27.78% | -36.27% |
| NESTLEIND | NESTLE INDIA LIMITED | 264,641.85 cr | 69.436659 | +95.04% | +13.51% |
| VBL | VARUN BEVERAGES LIMITED | 142,715.98 cr | 42.097372 | +18.59% | -10.90% |
| BRITANNIA | BRITANNIA INDUSTRIES LTD | 120,385.98 cr | 46.485738 | +54.42% | -18.07% |
| MARICO | MARICO LIMITED | 104,169.59 cr | 55.174569 | +43.11% | +11.69% |
| UNITDSPR | UNITED SPIRITS LIMITED | 99,719.81 cr | 52.929835 | +22.09% | +3.28% |
| TATACONSUM | TATA CONSUMER PRODUCT LTD | 98,560.70 cr | 60.551387 | +7.30% | -11.80% |
Try these prompts
- Analyze NATH BIO-GENES (I) with valuation, momentum and industry peers
- Compare NATHBIOGEN with other Fast Moving Consumer Goods stocks
- Show small-cap stocks in Fast Moving Consumer Goods above 50DMA with positive 1M return
- Find Fast Moving Consumer Goods stocks with improving momentum and reasonable valuation
Related screen ideas
- View Fast Moving Consumer Goods stocks
- View small-cap stocks
- Find stocks above 50DMA
- Compare NATHBIOGEN with other Fast Moving Consumer Goods stocks
Data snapshot: 2026-09-18. Not investment advice.